Acknowledgements Abbreviations 1. Introduction 2. Commonly used terms and key definitions in DR-TB treatment 3. Key considerations in DR-TB treatment 4. The 6-month bedaquiline, pretomanid, linezolid and moxifloxacin (BPaLM) regimen 5. The 9-month all-oral regimen 6. The longer regimens 7. Regimen for rifampicin susceptible and isoniazid resistant TB 8. Adjuncts to MDR-TB treatment 9. Programmatic implementation of MDR-TB regimens 10. Treatment outcome definitions References Annex Liens transversaux de livre pour Module 4: Drug-resistant tuberculosis treatment, 2022 update ‹ Haut › treatment VIEW PDF VERSION Download PPT Guidance Category Treatment